Component

Calcium signaling in mouse intestinal L cells

Calcium signaling in mouse intestinal L cells. Interpret through the linked study species, preparation, exposure and measured endpoint.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Glucose-induced calcium signaling persisted during TRPA1 antagonist exposure in the tested mouse L cells.

    Experimental context and source evidence
    evidence_access
    Primary full text available; selected claim-relevant methods, results, tables/figures and limitations reviewed. Supplemental proteome and all secondary findings are not exhaustively extracted.
    experimental_condition
    Glucose response without antagonist pharmacologically blocked · Mouse Trpa1 ion channel Condition belongs to the full experimental contrast; do not separate a joint intervention.
    experimental_condition
    Glucose response without antagonist stimulus · D-glucose Condition belongs to the full experimental contrast; do not separate a joint intervention.
    experimental_contrast
    {"intervention": "Glucose response with TRPA1 antagonist", "comparator": "Glucose response without antagonist", "endpoint": "Glucose-induced calcium signaling persisted during TRPA1 antagonist exposure in the tested mouse L cells.", "effect_direction": "no_detected_change", "combination": "joint", "conditions": [{"entity_slug": "glucose", "state": "stimulus"}, {"entity_slug": "mouse-trpa1", "state": "pharmacologically blocked"}]} Explicit extracted experimental comparison; source-derived draft.
    experimental_model
    Mouse primary L cells; 10 mM glucose with or without A-967079.
    interpretation_status
    Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
    limitations
    No loss of glucose response in this assay; not a general role for allicin in glycemic control.
    plain_language
    Glucose-induced calcium signaling persisted during TRPA1 antagonist exposure in the tested mouse L cells.
    primary_references
    Stimulation of GLP-1 secretion downstream of the ligand-gated ion channel TRPA1. | 2015 | DOI 10.2337/db14-0737 | PMID 25325736 | https://pubmed.ncbi.nlm.nih.gov/25325736/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC4375100/ | https://doi.org/10.2337/db14-0737
    source_locator
    Reviewed reference lines 75-75; exact primary location described in quoted passage where extracted.

    Allicin: detailed mechanisms of action (reviewed 5 October 2026) · lines 75–75

    Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Mouse primary L cells; 10 mM glucose with or without A-967079. · Recorded from source · Recorded from source

    **The GLP-1 experiment did not test allicin.** Allyl isothiocyanate (AITC) and carvacrol increased calcium signaling and GLP-1 secretion in mouse intestinal cultures; antagonism or Trpa1 deletion limited those responses. Glucose-induced responses persisted during TRPA1 blockade. In vivo, oral AITC at 15 mg/kg raised GLP-1 even in Trpa1-null mice; lower doses did not significantly increase it. Capsaicin did not increase secretion in the tested cultures. These findings constrain a proposed allicin–TRPA1–GLP-1 connection, but they do not demonstrate it. AITC is not allicin. [Emery 2015](https://pmc.ncbi.nlm.nih.gov/articles/PMC4375100/)
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.